341 related articles for article (PubMed ID: 12832668)
1. Effect of cilomilast (Ariflo) on TNF-alpha, IL-8, and GM-CSF release by airway cells of patients with COPD.
Profita M; Chiappara G; Mirabella F; Di Giorgi R; Chimenti L; Costanzo G; Riccobono L; Bellia V; Bousquet J; Vignola AM
Thorax; 2003 Jul; 58(7):573-9. PubMed ID: 12832668
[TBL] [Abstract][Full Text] [Related]
2. Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease.
Gamble E; Grootendorst DC; Brightling CE; Troy S; Qiu Y; Zhu J; Parker D; Matin D; Majumdar S; Vignola AM; Kroegel C; Morell F; Hansel TT; Rennard SI; Compton C; Amit O; Tat T; Edelson J; Pavord ID; Rabe KF; Barnes NC; Jeffery PK
Am J Respir Crit Care Med; 2003 Oct; 168(8):976-82. PubMed ID: 12816740
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease.
Knobloch J; Sibbing B; Jungck D; Lin Y; Urban K; Stoelben E; Strauch J; Koch A
J Pharmacol Exp Ther; 2010 Dec; 335(3):788-98. PubMed ID: 20801891
[TBL] [Abstract][Full Text] [Related]
4. The phosphodiesterase type IV inhibitor cilomilast decreases pro-inflammatory cytokine production from primary bronchial epithelial cells in lung transplantation patients.
Murphy DM; Ward C; Forrest IA; Pritchard G; Jones D; Stovold R; Fisher AJ; Cawston TE; Lordan JL; Corris PA
J Heart Lung Transplant; 2006 Dec; 25(12):1436-40. PubMed ID: 17178338
[TBL] [Abstract][Full Text] [Related]
5. Cilomilast.
Schachter EN
Drugs Today (Barc); 2006 Apr; 42(4):237-47. PubMed ID: 16703120
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPD.
Saha S; Doe C; Mistry V; Siddiqui S; Parker D; Sleeman M; Cohen ES; Brightling CE
Thorax; 2009 Aug; 64(8):671-6. PubMed ID: 19213775
[TBL] [Abstract][Full Text] [Related]
7. Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease.
Giembycz MA
Expert Opin Investig Drugs; 2001 Jul; 10(7):1361-79. PubMed ID: 11772257
[TBL] [Abstract][Full Text] [Related]
8. The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-alpha production in whole blood from COPD patients.
Ouagued M; Martin-Chouly CA; Brinchault G; Leportier-Comoy C; Depincé A; Bertrand C; Lagente V; Belleguic C; Pruniaux MP
Pulm Pharmacol Ther; 2005; 18(1):49-54. PubMed ID: 15607127
[TBL] [Abstract][Full Text] [Related]
9. Cilomilast counteracts the effects of cigarette smoke in airway epithelial cells.
Pace E; Ferraro M; Uasuf CG; Giarratano A; La Grutta S; Liotta G; Johnson M; Gjomarkaj M
Cell Immunol; 2011; 268(1):47-53. PubMed ID: 21382614
[TBL] [Abstract][Full Text] [Related]
10. Procaterol inhibits IL-1beta- and TNF-alpha-mediated epithelial cell eosinophil chemotactic activity.
Koyama S; Sato E; Masubuchi T; Takamizawa A; Kubo K; Nagai S; Isumi T
Eur Respir J; 1999 Oct; 14(4):767-75. PubMed ID: 10573218
[TBL] [Abstract][Full Text] [Related]
11. KF19514, a phosphodiesterase 4 and 1 inhibitor, inhibits TNF-alpha-induced GM-CSF production by a human bronchial epithelial cell line via inhibition of PDE4.
Sasaki K; Manabe H
Inflamm Res; 2004 Jan; 53(1):31-7. PubMed ID: 15021978
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with theophylline reduces neutrophils, interleukin-8 and tumor necrosis factor-alpha in the sputum of patients with chronic obstructive pulmonary disease.
Iiboshi H; Ashitani J; Katoh S; Sano A; Matsumoto N; Mukae H; Nakazato M
Pulm Pharmacol Ther; 2007; 20(1):46-51. PubMed ID: 16413994
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of cilomilast in COPD.
Rennard S; Knobil K; Rabe KF; Morris A; Schachter N; Locantore N; Canonica WG; Zhu Y; Barnhart F
Drugs; 2008; 68 Suppl 2():3-57. PubMed ID: 19105585
[TBL] [Abstract][Full Text] [Related]
14. Increased sputum IL-8 and IL-5 in asymptomatic nonspecific airway hyperresponsiveness.
Betz R; Kohlhäufl M; Kassner G; Müllinger B; Maier K; Brand P; Weber N; Häussinger K; Heyder J; Frankenberger M
Lung; 2001; 179(2):119-33. PubMed ID: 11733854
[TBL] [Abstract][Full Text] [Related]
15. Effect of theophylline on endogenous hydrogen sulfide production in patients with COPD.
Chen YH; Yao WZ; Ding YL; Geng B; Lu M; Tang CS
Pulm Pharmacol Ther; 2008; 21(1):40-6. PubMed ID: 17196413
[TBL] [Abstract][Full Text] [Related]
16. IL-5, IL-8 and GM-CSF immunostaining of sputum cells in bronchial asthma and chronic bronchitis.
Hoshi H; Ohno I; Honma M; Tanno Y; Yamauchi K; Tamura G; Shirato K
Clin Exp Allergy; 1995 Aug; 25(8):720-8. PubMed ID: 7584683
[TBL] [Abstract][Full Text] [Related]
17. Bronchial epithelial cells produce CXCL1 in response to LPS and TNFα: A potential role in the pathogenesis of COPD.
Inui T; Watanabe M; Nakamoto K; Sada M; Hirata A; Nakamura M; Honda K; Ogawa Y; Takata S; Yokoyama T; Saraya T; Kurai D; Wada H; Ishii H; Takizawa H
Exp Lung Res; 2018 Sep; 44(7):323-331. PubMed ID: 30676127
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacology of Cilomilast.
Down G; Siederer S; Lim S; Daley-Yates P
Clin Pharmacokinet; 2006; 45(3):217-33. PubMed ID: 16509757
[TBL] [Abstract][Full Text] [Related]
19. [IL-1 and TNF-alpha-mediated regulation of IL-6, IL-8, and GM-CSF release from cultured nasal epithelial cells].
Yamagishi S; Ohnishi M; Pawankar R
Nihon Jibiinkoka Gakkai Kaiho; 2000 Jul; 103(7):829-35. PubMed ID: 10946556
[TBL] [Abstract][Full Text] [Related]
20. IL-17A-associated IKK-α signaling induced TSLP production in epithelial cells of COPD patients.
Anzalone G; Albano GD; Montalbano AM; Riccobono L; Bonanno A; Gagliardo R; Bucchieri F; Marchese R; Moscato M; Profita M
Exp Mol Med; 2018 Oct; 50(10):1-12. PubMed ID: 30291224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
